TABLE 6.

Biochemical parameters assessment in control and intervention group at baseline and post-intervention.

Outcomes	Control group (n = 24)1				Intervention group (n = 22)1
	Baseline mean (±SD) median (P25;P75)	Post-intervention mean (±SD) median (P25;P75)	Post-intervention Δ mean (±SD) Δ median (P25; P75)	Within-group analysis p-value	Baseline mean (±SD) median (P25;P75)	Post-intervention mean (±SD) median (P25;P75)	Post-intervention Δ mean (±SD) Δ median (P25; P75)	Within-group analysis p-value
hs-CRP (mg/dL)	0.33 (±0.32) 0.24 (0.09; 0.43)	0.36 (±0.44) 0.23 (0.09; 0.49)	0.03 (±0.29) −0.03 (−0.15; 0.09)	0.920a	0.32 (±0.27) 0.21 (0.11; 0.53)	0.37 (±0.34) 0.19 (0.11; 0.62)	0.04 (±0.26) −0.0 (0.08; 0.15)	0.745a
ESR (mm)	10.42 (±8.20) 7.5 (5.0; 14.5)	9.88 (±8.83) 7.0 (5.0; 15.75)	−0.54 (±4.90) −0.5 (−3.0; 2.75)	0.663a	11.36 (±8.29) 8.0 (5.0; 14.25)	11.64 (±11.16) 8.50 (4.0; 13.75)	0.27 (±6.69) 0.0 (−4.3; 3.25)	0.794a

¹Female participants.

hs-CRP, high-sensitive C-Reactive Protein; ESR, Erythrocyte Sedimentation Rate.

^ap-value calculated by Wilcoxon Test between baseline and post-intervention, within-groups mean values;

^bp-value calculated by Paired Samples t-test between baseline and post-intervention, within-groups mean values.